| INSPIRE PHARM (ISPH) |
|
|
| NASDAQ:ISPH |
Last Trade: Today @ 5:20:01 PM |
| Last Price: 5.12 |
Change: ($-0.01 -0.195%) |
| Open: |
5.17 |
Prev. Close: |
5.13 |
| Day's High: |
5.25 |
Low: |
5.07 |
| 52-Week High: |
8.70 |
52-Week Low: |
3.59 |
| Bid: |
5.10 / 9,300 |
Ask: |
5.11 / 3,200 |
| Volume: |
277,448 |
Outstanding: |
0 |
| Market cap: |
-
|
|
|
|
|
| Inspire Pharmaceuticals is a biopharmaceutical company engaged in discovering, developing and commercializing prescription pharmaceutical products focusing in the ophthalmic and respiratory/allergy therapeutic areas. Co.'s ophthalmic products, Elestat and Restasis , as well as its product candidates, are concentrated in the allergic and bacterial conjunctivitis, dry eye disease, and glaucoma indications, while its respiratory/allergy product candidates are concentrated in the treatment of respiratory complications of cystic fibrosis and seasonal allergic rhinitis indications. As of Dec 31 2006, Co. co-promoted Elestat and Restasis in the U.S. under agreements with Allergan, Inc. |
INSPIRE PHARM Press ReleasesChartpoppers.com releases Investment overview on Inspire Pharmaceuticals Inc. - Wednesday, March 10, 2010
Inspire Announces Grants Under NASDAQ Marketplace Rule 5635 - Tuesday, February 23, 2010
Inspire Announces Date for Conference Call and Webcast to Discuss Third Quarter 2008 Financial Resul - Friday, October 17, 2008
Get this stock quote and other market data from XML Stock Quotes.com
|
